SEC Form 4 · accession 0001645627-17-000102
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 31, 2017
Accepted (ET)
Aug 2, 2017 · 1:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2017 | P | 2,000 | $0.037 | A | 22,077,889 | D | |
| Common Stock | Jul 31, 2017 | P | 2,000 | $0.036 | A | 22,079,889 | D | |
| Common Stock | Jul 31, 2017 | P | 2,000 | $0.035 | A | 22,081,889 | D | |
| Common Stock | Aug 1, 2017 | P | 3,000 | $0.0348 | A | 22,084,889 | D | |
| Common Stock | Aug 1, 2017 | P | 2,000 | $0.0347 | A | 22,086,889 | D | |
| Common Stock | Aug 1, 2017 | P | 3,500 | $0.0347 | A | 22,090,389 | D | |
| Common Stock | Aug 1, 2017 | P | 2,000 | $0.031 | A | 22,092,389 | D | |
| Common Stock | Aug 1, 2017 | P | 3,000 | $0.031 | A | 22,095,389 | D | |
| Common Stock | Aug 1, 2017 | P | 3,000 | $0.0309 | A | 22,098,389 | D | |
| Common Stock | Aug 1, 2017 | P | 3,000 | $0.031 | A | 22,101,389 | D | |
| Common Stock | Aug 1, 2017 | P | 5,000 | $0.031 | A | 22,106,389 | D | |
| Common Stock | Aug 1, 2017 | P | 2,000 | $0.031 | A | 22,108,389 | D | |
| Common Stock | Aug 1, 2017 | P | 5,000 | $0.0309 | A | 22,113,389 | D | |
| Common Stock | Aug 1, 2017 | P | 5,000 | $0.031 | A | 22,118,389 | D | |
| Common Stock | Aug 1, 2017 | P | 5,000 | $0.031 | A | 22,123,389 | D | |
| Common Stock | Aug 1, 2017 | P | 2,000 | $0.0309 | A | 22,125,389 | D | |
| Common Stock | Aug 1, 2017 | P | 5,000 | $0.0309 | A | 22,130,389 | D | |
| Common Stock | Aug 1, 2017 | P | 2,000 | $0.0319 | A | 22,132,389 | D | |
| Common Stock | Aug 1, 2017 | P | 5,000 | $0.0319 | A | 22,137,389 | D | |
| Common Stock | Aug 1, 2017 | P | 2,000 | $0.031 | A | 22,139,389 | D | |
| Common Stock | Aug 1, 2017 | P | 2,000 | $0.0339 | A | 22,141,389 | D |
Table II — derivative securities
No Table II lines on this filing.